Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.236
-0.023 (-8.87%)
At close: Feb 27, 2026, 4:00 PM EST
0.243
+0.007 (2.96%)
After-hours: Feb 27, 2026, 7:49 PM EST
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $10.69 million as of February 27, 2026. Its market cap has decreased by -66.06% in one year.
Market Cap
10.69M
Enterprise Value
10.43M
1-Year Change
-66.06%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $10.69M, a decrease of -96.33%. That is a compound annual growth rate of -27.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iterum Therapeutics | 12.52M |
| CytoMed Therapeutics | 12.46M |
| GT Biopharma | 12.01M |
| Soligenix | 11.90M |
| Pulmatrix | 11.76M |
| Moolec Science | 11.71M |
| Longeveron | 11.70M |
| KALA BIO | 11.41M |